BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2670659)

  • 1. Sclerotherapy-associated esophageal ulcers: lessons from a double-blind, randomized comparison of sucralfate suspension versus placebo.
    Tabibian N; Smith JL; Graham DY
    Gastrointest Endosc; 1989; 35(4):312-5. PubMed ID: 2670659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ulceration after esophageal and gastric variceal sclerotherapy--influence of sucralfate and other factors on healing.
    Singal AK; Sarin SK; Misra SP; Broor SL
    Endoscopy; 1988 Sep; 20(5):238-40. PubMed ID: 3168936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of sucralfate with placebo in the treatment of esophageal ulcers following therapeutic endoscopic sclerotherapy of esophageal varices--a prospective controlled randomized trial.
    Paquet KJ; Koussouris P; Keinath R; Rambach W; Kalk JF
    Am J Med; 1991 Aug; 91(2A):147S-150S. PubMed ID: 1882901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sucralfate granules in suspension on endoscopic variceal sclerotherapy induced ulcer: analysis of the factors determining ulcer healing.
    Yang WG; Hou MC; Lin HC; Kuo BI; Lee FY; Chang FY; Lee SD
    J Gastroenterol Hepatol; 1998 Feb; 13(2):225-31. PubMed ID: 10221828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sucralfate for the prevention of early rebleeding following injection sclerotherapy for esophageal varices.
    Polson RJ; Westaby D; Gimson AE; Hayes PC; Stellon AJ; Hayllar K; Williams R
    Hepatology; 1989 Sep; 10(3):279-82. PubMed ID: 2788116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sucralfate suspension 1 g four times per day in the short-term treatment of active duodenal ulcer.
    Martin F
    Am J Med; 1989 Jun; 86(6A):104-7. PubMed ID: 2660550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of stomach ulcer with sucralfate and ranitidine. A multicenter double-blind study].
    Blum AL; Bode JC; Domschke W; Feurle G; Hackenberg K; Hammer B; Hüttemann W; Kachel G; Kaess H; Manegold BC
    Dtsch Med Wochenschr; 1986 Dec; 111(50):1910-5. PubMed ID: 3536400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute alcohol in esophageal vein sclerosis.
    Paoluzi P; Pietroiusti A; Ferrari S; Cappa M; Pagnanelli A
    Gastrointest Endosc; 1988; 34(5):400-2. PubMed ID: 3053320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twice-daily sucralfate dosing to heal acute duodenal ulcer. Multicenter Study Group.
    Schubert T
    Am J Med; 1989 Jun; 86(6A):108-12. PubMed ID: 2660551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of postsclerotherapy esophageal ulcers with sucralfate.
    Roark G
    Gastrointest Endosc; 1984 Feb; 30(1):9-10. PubMed ID: 6608468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance therapy with sucralfate in duodenal ulcer: genuine prevention or accelerated healing of ulcer recurrence?
    Bynum TE; Koch GG
    Am J Med; 1991 Aug; 91(2A):84S-90S. PubMed ID: 1882909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post sclerotherapy esophageal ulcers: a prospective analysis of their behaviour.
    Choudhuri G; Agrawal BK; Tantry BV; Prakash V; Kumar P
    Indian J Gastroenterol; 1989 Jan; 8(1):19-21. PubMed ID: 2783682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidiasis complicating sclerotherapy-induced esophageal ulcer presenting as recurrent hematemesis.
    Goenka MK; Thapa BR; Jethi SC; Mehta S
    Indian J Gastroenterol; 1989 Jul; 8(3):187-8. PubMed ID: 2787290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter trial of sucralfate suspension for the treatment of reflux esophagitis.
    Williams RM; Orlando RC; Bozymski EM; Readling RD; Castell DO; Roufail WM; Rick GG; Rubin SE; Sinar DR
    Am J Med; 1987 Sep; 83(3B):61-6. PubMed ID: 3310630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of omeprazole in prevention and treatment of postendoscopic variceal sclerotherapy esophageal complications. Double-blind randomized study.
    Garg PK; Sidhu SS; Bhargava DK
    Dig Dis Sci; 1995 Jul; 40(7):1569-74. PubMed ID: 7628284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sucralfate tablets 1 g twice a day for the prevention of duodenal ulcer recurrence.
    Bynum TE; Koch GG
    Am J Med; 1989 Jun; 86(6A):127-32. PubMed ID: 2660555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sucralfate in the treatment and prevention of gastric ulcer: multicentre double blind placebo controlled study.
    Blum AL; Bethge H; Bode JC; Domschke W; Feurle G; Hackenberg K; Hammer B; Hüttemann W; Jung M; Kachel G
    Gut; 1990 Jul; 31(7):825-30. PubMed ID: 2196208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of sucralfate in corpus, prepyloric, and duodenal ulcer-associated gastric ulcers. A double-blind, placebo-controlled study.
    Lam SK; Lau WY; Lai CL; Lee NW; Poon GP; Hui WM; Lok AS; Ng MM; Fok KH; Yu HC
    Am J Med; 1985 Aug; 79(2C):24-31. PubMed ID: 3898832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of sucralfate for duodenal ulcers: a multicenter, double-blind trial.
    Hollander D
    J Clin Gastroenterol; 1981; 3(Suppl 2):153-7. PubMed ID: 7033352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term treatment of prepyloric ulcer. Comparison of sucralfate and cimetidine.
    Svedberg LE; Carling L; Glise H; Hallerbäck B; Kagevi I; Solhaug JH; Wählby L
    Dig Dis Sci; 1987 Mar; 32(3):225-31. PubMed ID: 3545718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.